金域医学
(603882)
| 流通市值：130.13亿 | | | 总市值：131.01亿 |
| 流通股本：4.60亿 | | | 总股本：4.63亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,335,834,378.52 | 2,851,347,169.78 | 2,442,660,458.1 | 2,177,060,105.01 |
| 交易性金融资产 | 12,773,259.75 | - | - | - |
| 应收票据及应收账款 | 3,392,529,449.41 | 3,352,535,325.3 | 3,827,036,361.93 | 4,120,803,795.2 |
| 其中：应收票据 | 800,000 | 600,000 | 200,000 | 10,024,044.46 |
| 应收账款 | 3,391,729,449.41 | 3,351,935,325.3 | 3,826,836,361.93 | 4,110,779,750.74 |
| 预付款项 | 15,947,269.09 | 8,620,641.06 | 14,154,016.54 | 9,267,774.62 |
| 其他应收款合计 | 81,105,737.95 | 85,938,908.93 | 85,433,737.69 | 78,722,135.67 |
| 存货 | 182,645,700.45 | 186,102,854.19 | 190,612,298.75 | 190,723,447.57 |
| 合同资产 | 61,174,641.36 | 23,171,935.09 | 63,867,755.79 | 20,427,003.08 |
| 其他流动资产 | 105,248,553.04 | 105,289,775.47 | 104,105,419.96 | 107,561,319.53 |
| 流动资产合计 | 6,187,258,989.57 | 6,613,006,609.82 | 6,727,870,048.76 | 6,704,565,580.68 |
| 非流动资产: | | | | |
| 长期股权投资 | 138,595,953.3 | 141,992,324.3 | 122,690,595.26 | 174,795,453.87 |
| 其他非流动金融资产 | 277,464,189.54 | 263,525,920.96 | 280,826,645.58 | 283,350,518.25 |
| 投资性房地产 | 17,995,489.04 | 18,192,963.37 | 18,390,437.76 | 25,332,297.14 |
| 固定资产 | 988,573,680.05 | 1,033,454,833.29 | 1,086,694,814.42 | 1,132,239,035.29 |
| 在建工程 | 788,054,338.81 | 731,318,161.76 | 634,246,042.81 | 628,999,197.35 |
| 使用权资产 | 154,371,062.61 | 140,582,120.32 | 158,293,133.99 | 170,762,079.44 |
| 无形资产 | 171,197,228.65 | 175,081,812.12 | 173,806,569.81 | 163,628,455.56 |
| 开发支出 | 6,950,589.67 | 6,496,381.87 | 5,890,702.67 | 5,093,805.62 |
| 商誉 | 42,056,653.43 | 42,056,653.43 | 52,205,371.01 | 52,205,371.01 |
| 长期待摊费用 | 101,939,631.05 | 117,548,629.53 | 133,281,404.68 | 146,073,051.92 |
| 递延所得税资产 | 313,298,962.51 | 309,998,678.69 | 301,670,931.82 | 287,067,948.89 |
| 其他非流动资产 | 12,650,952.58 | 11,275,235.84 | 18,039,112.27 | 9,392,486.44 |
| 非流动资产合计 | 3,013,148,731.24 | 2,991,523,715.48 | 2,986,035,762.08 | 3,078,939,700.78 |
| 资产总计 | 9,200,407,720.81 | 9,604,530,325.3 | 9,713,905,810.84 | 9,783,505,281.46 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 1,477,838,317.18 | 1,486,179,126.96 | 1,560,749,315.53 | 1,693,079,630.77 |
| 应付账款 | 1,477,838,317.18 | 1,486,179,126.96 | 1,560,749,315.53 | 1,693,079,630.77 |
| 合同负债 | 64,391,135.86 | 64,035,840.63 | 67,951,017.91 | 63,441,467.13 |
| 应付职工薪酬 | 144,618,696.8 | 198,355,145.29 | 152,235,721.96 | 130,725,704.9 |
| 应交税费 | 40,395,268.05 | 43,618,682.69 | 64,598,250.24 | 39,415,825.12 |
| 其他应付款合计 | 95,906,335.38 | 82,359,726.53 | 86,988,849.34 | 91,972,363.69 |
| 一年内到期的非流动负债 | 154,475,075.94 | 167,267,402.82 | 209,022,236.86 | 153,781,381.86 |
| 其他流动负债 | 350,968.02 | 338,270.99 | 354,417.43 | 278,333.76 |
| 流动负债合计 | 1,977,975,797.23 | 2,042,154,195.91 | 2,141,899,809.27 | 2,172,694,707.23 |
| 非流动负债: | | | | |
| 长期借款 | 589,218,742.57 | 575,735,208.99 | 474,607,743.47 | 509,032,743.47 |
| 租赁负债 | 114,078,545.44 | 92,643,394.43 | 103,197,604.24 | 109,503,589.3 |
| 递延收益 | 15,447,938.21 | 14,602,333.6 | 17,656,683.01 | 18,699,157.75 |
| 递延所得税负债 | 20,677,574.42 | 20,845,104.79 | 22,771,878.05 | 25,509,599.29 |
| 非流动负债合计 | 739,422,800.64 | 703,826,041.81 | 618,233,908.77 | 662,745,089.81 |
| 负债合计 | 2,717,398,597.87 | 2,745,980,237.72 | 2,760,133,718.04 | 2,835,439,797.04 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 463,258,275 | 463,258,275 | 463,258,275 | 463,258,275 |
| 资本公积 | 1,169,645,248.52 | 1,169,645,248.52 | 1,169,645,248.52 | 1,171,063,209.99 |
| 其他综合收益 | 7,349,735.34 | 23,106,172.9 | 28,521,424.3 | 28,388,879.5 |
| 盈余公积 | 234,385,637.5 | 234,385,637.5 | 234,385,637.5 | 234,385,637.5 |
| 未分配利润 | 4,474,114,689.59 | 4,838,991,421.81 | 4,932,625,436.28 | 4,927,428,147.75 |
| 归属于母公司股东权益合计 | 6,348,753,585.95 | 6,729,386,755.73 | 6,828,436,021.6 | 6,824,524,149.74 |
| 少数股东权益 | 134,255,536.99 | 129,163,331.85 | 125,336,071.2 | 123,541,334.68 |
| 股东权益合计 | 6,483,009,122.94 | 6,858,550,087.58 | 6,953,772,092.8 | 6,948,065,484.42 |
| 负债和股东权益合计 | 9,200,407,720.81 | 9,604,530,325.3 | 9,713,905,810.84 | 9,783,505,281.46 |
| 公告日期 | 2026-04-25 | 2026-04-25 | 2025-10-30 | 2025-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |